SYROS PHARMACEUTICALS INC's ticker is SYRS and the CUSIP is 87184Q107. A total of 64 filers reported holding SYROS PHARMACEUTICALS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2022 | $4,000 | -33.3% | 4,593 | -13.8% | 0.00% | – |
Q1 2022 | $6,000 | -64.7% | 5,328 | 0.0% | 0.00% | – |
Q4 2021 | $17,000 | -29.2% | 5,328 | 0.0% | 0.00% | – |
Q3 2021 | $24,000 | -17.2% | 5,328 | 0.0% | 0.00% | – |
Q2 2021 | $29,000 | -25.6% | 5,328 | +3.5% | 0.00% | – |
Q1 2021 | $39,000 | -79.4% | 5,148 | -70.4% | 0.00% | – |
Q4 2020 | $189,000 | +320.0% | 17,405 | +238.7% | 0.00% | – |
Q3 2020 | $45,000 | -38.4% | 5,139 | -24.9% | 0.00% | – |
Q2 2020 | $73,000 | +135.5% | 6,844 | +19.8% | 0.00% | – |
Q1 2020 | $31,000 | -36.7% | 5,713 | -20.2% | 0.00% | – |
Q4 2019 | $49,000 | -18.3% | 7,158 | +23.6% | 0.00% | – |
Q3 2019 | $60,000 | +30.4% | 5,791 | 0.0% | 0.00% | – |
Q2 2019 | $46,000 | +15.0% | 5,791 | +31.0% | 0.00% | – |
Q1 2019 | $40,000 | +100.0% | 4,420 | +21.3% | 0.00% | – |
Q4 2018 | $20,000 | -53.5% | 3,645 | 0.0% | 0.00% | – |
Q3 2018 | $43,000 | +16.2% | 3,645 | 0.0% | 0.00% | – |
Q2 2018 | $37,000 | +12.1% | 3,645 | +41.6% | 0.00% | – |
Q1 2018 | $33,000 | -5.7% | 2,574 | -28.6% | 0.00% | – |
Q4 2017 | $35,000 | -23.9% | 3,604 | +15.8% | 0.00% | – |
Q3 2017 | $46,000 | +27.8% | 3,112 | +42.3% | 0.00% | – |
Q2 2017 | $36,000 | +300.0% | 2,187 | +275.1% | 0.00% | – |
Q1 2017 | $9,000 | +28.6% | 583 | 0.0% | 0.00% | – |
Q4 2016 | $7,000 | – | 583 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Ally Bridge Group (NY) LLC | 3,139,895 | $23,486,000 | 4.50% |
Samsara BioCapital, LLC | 2,189,199 | $14,769,000 | 2.72% |
Bain Capital Life Sciences Investors, LLC | 5,785,036 | $43,272,000 | 2.45% |
Omega Fund Management, LLC | 1,562,500 | $11,688,000 | 1.11% |
Flagship Pioneering Inc. | 2,938,494 | $21,980,000 | 0.35% |
EcoR1 Capital, LLC | 1,000,000 | $7,480,000 | 0.33% |
Altium Capital Management LP | 126,702 | $948,000 | 0.26% |
Nikko Asset Management Americas, Inc. | 5,042,009 | $37,714,000 | 0.18% |
Artal Group S.A. | 1,025,000 | $7,667,000 | 0.14% |
Orbimed Advisors | 1,837,500 | $13,745,000 | 0.13% |